Nothing Special   »   [go: up one dir, main page]

ATE508742T1 - Kombination eines inhibitoren des if-herzstromes am sinusknoten und eines inhibitoren des angiotensin-umwandelnden enzyms - Google Patents

Kombination eines inhibitoren des if-herzstromes am sinusknoten und eines inhibitoren des angiotensin-umwandelnden enzyms

Info

Publication number
ATE508742T1
ATE508742T1 AT06291993T AT06291993T ATE508742T1 AT E508742 T1 ATE508742 T1 AT E508742T1 AT 06291993 T AT06291993 T AT 06291993T AT 06291993 T AT06291993 T AT 06291993T AT E508742 T1 ATE508742 T1 AT E508742T1
Authority
AT
Austria
Prior art keywords
inhibitor
sinous
cardial
node
combination
Prior art date
Application number
AT06291993T
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE508742(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE508742T1 publication Critical patent/ATE508742T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
AT06291993T 2005-12-21 2006-12-20 Kombination eines inhibitoren des if-herzstromes am sinusknoten und eines inhibitoren des angiotensin-umwandelnden enzyms ATE508742T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
ATE508742T1 true ATE508742T1 (de) 2011-05-15

Family

ID=36685870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06291993T ATE508742T1 (de) 2005-12-21 2006-12-20 Kombination eines inhibitoren des if-herzstromes am sinusknoten und eines inhibitoren des angiotensin-umwandelnden enzyms

Country Status (42)

Country Link
US (2) US20070142355A1 (de)
EP (2) EP2298297A1 (de)
JP (2) JP4705564B2 (de)
KR (2) KR100907583B1 (de)
CN (1) CN101015557B (de)
AP (1) AP2119A (de)
AR (1) AR058574A1 (de)
AT (1) ATE508742T1 (de)
AU (1) AU2006252210B2 (de)
BR (1) BRPI0605517A (de)
CA (1) CA2571644C (de)
CO (1) CO5790168A1 (de)
CR (1) CR8820A (de)
CY (1) CY1111575T1 (de)
DK (1) DK1800678T3 (de)
EA (1) EA011253B1 (de)
ES (1) ES2366570T3 (de)
FR (1) FR2894825B1 (de)
GE (1) GEP20094604B (de)
GT (1) GT200600522A (de)
HK (1) HK1106444A1 (de)
HR (1) HRP20110532T1 (de)
IL (1) IL180204A (de)
JO (1) JO2699B1 (de)
MA (1) MA28723B1 (de)
ME (1) ME01958B (de)
MX (1) MXPA06014885A (de)
MY (1) MY146956A (de)
NO (1) NO337640B1 (de)
NZ (1) NZ552221A (de)
PE (2) PE20110116A1 (de)
PL (1) PL1800678T3 (de)
PT (1) PT1800678E (de)
RS (1) RS51731B (de)
SA (1) SA06270480B1 (de)
SG (2) SG133545A1 (de)
SI (1) SI1800678T1 (de)
TW (1) TWI369206B (de)
UA (1) UA86417C2 (de)
UY (1) UY30023A1 (de)
WO (1) WO2007077327A1 (de)
ZA (1) ZA200610824B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
JP2005516888A (ja) * 2001-06-08 2005-06-09 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 過分極活性化型環状ヌクレオチド依存性チャンネルに標的を定めることによる疼痛の治療
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
WO2003024457A1 (fr) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Composition medicinale pour la prevention ou le traitement des troubles vasculaires cerebraux et de la cardiopathie
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
ATE257384T1 (de) * 2002-07-25 2004-01-15 Boehringer Ingelheim Pharma Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
CN101015557B (zh) 2010-12-08
JP2007169283A (ja) 2007-07-05
HRP20110532T1 (hr) 2011-08-31
SG173243A1 (en) 2011-08-29
KR20090047424A (ko) 2009-05-12
CN101015557A (zh) 2007-08-15
NZ552221A (en) 2008-05-30
SA06270480B1 (ar) 2011-02-23
HK1106444A1 (en) 2008-03-14
CA2571644A1 (fr) 2007-06-21
NO20065905L (no) 2007-06-22
JP4705564B2 (ja) 2011-06-22
CR8820A (es) 2007-08-28
GEP20094604B (en) 2009-02-10
US20070142355A1 (en) 2007-06-21
AU2006252210B2 (en) 2012-04-26
AR058574A1 (es) 2008-02-13
EP2298297A1 (de) 2011-03-23
SI1800678T1 (sl) 2011-08-31
PE20110116A1 (es) 2011-03-02
EP1800678A1 (de) 2007-06-27
ES2366570T3 (es) 2011-10-21
UA86417C2 (ru) 2009-04-27
GT200600522A (es) 2007-07-25
JO2699B1 (en) 2013-03-03
FR2894825A1 (fr) 2007-06-22
CA2571644C (fr) 2011-03-08
EA011253B1 (ru) 2009-02-27
PL1800678T3 (pl) 2011-08-31
DK1800678T3 (da) 2011-08-15
PE20071004A1 (es) 2007-11-17
UY30023A1 (es) 2007-01-31
CY1111575T1 (el) 2015-10-07
KR20070066921A (ko) 2007-06-27
BRPI0605517A (pt) 2007-10-16
MXPA06014885A (es) 2009-02-11
US20120196850A1 (en) 2012-08-02
SG133545A1 (en) 2007-07-30
TW200744608A (en) 2007-12-16
ZA200610824B (en) 2008-06-25
CO5790168A1 (es) 2007-08-31
ME01958B (de) 2011-10-31
PT1800678E (pt) 2011-07-12
IL180204A (en) 2014-02-27
KR100907583B1 (ko) 2009-07-14
WO2007077327A1 (fr) 2007-07-12
MA28723B1 (fr) 2007-07-02
JP2011079854A (ja) 2011-04-21
RS51731B (en) 2011-10-31
AP2006003859A0 (en) 2006-12-31
AU2006252210A1 (en) 2007-07-05
NO337640B1 (no) 2016-05-23
MY146956A (en) 2012-10-15
AP2119A (en) 2010-04-21
TWI369206B (en) 2012-08-01
FR2894825B1 (fr) 2010-12-03
IL180204A0 (en) 2008-01-20
EA200602155A1 (ru) 2007-08-31
EP1800678B1 (de) 2011-05-11

Similar Documents

Publication Publication Date Title
ATE508742T1 (de) Kombination eines inhibitoren des if-herzstromes am sinusknoten und eines inhibitoren des angiotensin-umwandelnden enzyms
ATE525374T1 (de) Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
DE602006021274D1 (de) Ultraschallvorrichtung und ultraschallverfahren
CR8540A (es) Inhibidores de serina proteasa ns-3 del vhc
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DE602006013239D1 (de) Dichtungsanordnung und Montageverfahren
MX2008006598A (es) Composiciones de edulcorante de alta potencia con vitamina y composiciones edulcoradas con la misma
MX2008006592A (es) Composiciones de edulcorante de alta potencia con calcio y composiciones edulcoradas con la misma
DE602005022454D1 (de) Enzymatische nachweistechniken
ATE369356T1 (de) Pyridazinon-derivate als cdk2-hemmer
ATE430892T1 (de) Flüssigkeits- und gasdichte röhrenförmige gewindeverbindung
DE602006021382D1 (de) Lautsprecher und Akustikausgabeverfahren
CR9850A (es) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
DE602006004255D1 (de) Wärme-Kraft-System
DK1842272T3 (da) Mellemspændingstilslutning til skibe
EP1929050A4 (de) Zusammensetzungen und verfahren zum nachweis von viren damit
DE602005002024D1 (de) Fernkopiersystem und Fernkopierverfahren
DE602006011795D1 (de) Zeitkorrelation zwischen Signalleistung und Verzerrungseigenschaften
DE602006003063D1 (de) Tripeptid- und tetrapeptidsulfone
ATE468342T1 (de) Azolopyridin-2-on-derivate als inhibitoren von lipasen und phospholipasen
ATE495163T1 (de) Benzothiazol-2-on-derivate als inhibitoren von lipasen und phospholipasen
DE602006019003D1 (de) Verstärkerschaltung und integrierte schaltung dafür
FR2920772B1 (fr) Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
DE602007002258D1 (de) Stromvorverstärker und damit verbundener Stromvergleicher
FR2876640B1 (fr) Van avec integration des roues et espace de service

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1800678

Country of ref document: EP